Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9448701rdf:typepubmed:Citationlld:pubmed
pubmed-article:9448701lifeskim:mentionsumls-concept:C0678133lld:lifeskim
pubmed-article:9448701lifeskim:mentionsumls-concept:C0029246lld:lifeskim
pubmed-article:9448701lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:9448701lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9448701lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:9448701lifeskim:mentionsumls-concept:C0165203lld:lifeskim
pubmed-article:9448701lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:9448701pubmed:issue8lld:pubmed
pubmed-article:9448701pubmed:dateCreated1998-2-4lld:pubmed
pubmed-article:9448701pubmed:abstractTextGeiparvarin, a natural product that exhibits antiproliferative activity, inhibits the growth of various tumour cell lines with a mechanism of action so far unknown. Our preliminary findings showed that geiparvarin and some derivatives obtained from its conjugation with diethylstilboestrol and meso-hexestrol significantly inhibit taxol-induced in vitro polymerization of both tubulin and microtubular protein. In this study we investigated the effect of geiparvarin and of the oestrogen-combined derivatives on the cellular microtubular network of fibroblasts. Geiparvarin altered the microtubular organization of fibroblasts and strengthened the derangement of the microtubular pattern in cells exposed simultaneously to taxol. However, the microtubular network remained quite well organized in fibroblasts exposed to geiparvarin and preincubated with taxol, which in this case prevented the deranging effect of the former. The antimicrotubular activity of the oestrogen-combined derivatives was more similar to that of geiparvarin than to that of the oestrogens, and often this activity was stronger than that of each reference drug alone; the cytotoxic activity examined in the same experimental conditions generally confirmed the microscopic analysis.lld:pubmed
pubmed-article:9448701pubmed:languageenglld:pubmed
pubmed-article:9448701pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448701pubmed:citationSubsetIMlld:pubmed
pubmed-article:9448701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9448701pubmed:statusMEDLINElld:pubmed
pubmed-article:9448701pubmed:monthDeclld:pubmed
pubmed-article:9448701pubmed:issn0266-9536lld:pubmed
pubmed-article:9448701pubmed:authorpubmed-author:MigliettaAAlld:pubmed
pubmed-article:9448701pubmed:authorpubmed-author:GabrielLLlld:pubmed
pubmed-article:9448701pubmed:authorpubmed-author:RamosLLlld:pubmed
pubmed-article:9448701pubmed:authorpubmed-author:BirzSSlld:pubmed
pubmed-article:9448701pubmed:authorpubmed-author:BoccaCClld:pubmed
pubmed-article:9448701pubmed:issnTypePrintlld:pubmed
pubmed-article:9448701pubmed:volume12lld:pubmed
pubmed-article:9448701pubmed:ownerNLMlld:pubmed
pubmed-article:9448701pubmed:authorsCompleteYlld:pubmed
pubmed-article:9448701pubmed:pagination607-20lld:pubmed
pubmed-article:9448701pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:meshHeadingpubmed-meshheading:9448701-...lld:pubmed
pubmed-article:9448701pubmed:year1997lld:pubmed
pubmed-article:9448701pubmed:articleTitleGeiparvarin and derivatives in combination with taxol: effect on microtubular organization in 3T3 fibroblasts.lld:pubmed
pubmed-article:9448701pubmed:affiliationDepartment of Experimental Medicine and Oncology, University of Torino, Italy.lld:pubmed
pubmed-article:9448701pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9448701pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed